Clinical Trial

To Test an e-Health Educational Intervention Patients With an ICD

Study acronym: CHOICE-ICD
Recruiting
View on ClinicalTrials.gov →
Summary
Role of the implantable cardioverter defibrillator (ICD) is to monitor heart rate and discharge a small electrical discharge or shock if the heart rate becomes life threatening. Patients and family members have requested more information about their ICD, how it works and how to live well with the device. This study will build on previous research by designing, in collaboration with patients, family members and professionals, an online resource to provide important information that can lower anxiety and concerns, and improve quality of life. The CHOICE-ICD resource will be easy to use, incorporating games and quizzes to encourage engagement, up to date information appropriate to each patient's needs, as well as animation clips, virtual reality, and short patient videos. CHOICE-ICD will be made available to 64 patients, in addition to normal care, awaiting or with a recently implanted ICD in Belfast and Glasgow. Patients will use the resource for 3 months. Patients and family members will then be asked to complete questionnaires and participate in semi-structured interviews. This study will develop 1st UK online resource providing information to enable patients to have greater choice and control in their care.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-04-01 -> 2026-12-01 2026-05-06
minor Completion pushed: 2026-04-01 -> 2026-12-01 2026-05-06
Trial Details
NCT Number NCT06667505
Lead Sponsor University of Ulster
Collaborators: Belfast Health and Social Care Trust, Golden Jubilee National Hospital
Conditions Implantable Cardioverter Defibrillator (ICD)
Enrollment 256 participants
Start Date 2025-08-11
Primary Completion 2026-12-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-05